Murine embryonic stem (ES) cells have unusually long telomeres, much longer than those in embryonic tissues. Here we address whether hyper-long telomeres are a natural property of pluripotent stem cells, such as those present at the blastocyst inner cell mass (ICM), or whether it is a characteristic acquired by the in vitro expansion of ES cells. We find that ICM cells undergo telomere elongation during the in vitro derivation of ES-cell lines. In vivo analysis shows that the hyper-long telomeres of morula-injected ES cells remain hyper-long at the blastocyst stage and longer than telomeres of the blastocyst ICM. Telomere lengthening during derivation of ES-cell lines is concomitant with a decrease in heterochromatic marks at telomeres. We also found increased levels of the telomere repeat binding factor 1 (TRF1) telomere-capping protein in cultured ICM cells before telomere elongation occurs, coinciding with expression of pluripotency markers. These results suggest that high TRF1 levels are present in pluripotent cells, most likely to ensure proficient capping of the newly synthesized telomeres. These results highlight a previously unnoticed difference between ICM cells at the blastocyst and ES cells, and suggest that abnormally long telomeres in ES cells are likely to result from continuous telomere lengthening of proliferating ICM cells locked at an epigenetic state associated to pluripotency.
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Nanog | Sox2 | Oct4 | embryo M ouse embryonic stem (ES) cells are pluripotent, proliferate indefinitely, and bear very long telomeres (1) (2) (3) . ES cells emerge from preimplantation blastocyst-stage embryos (4), but how this process takes place is largely unknown. In previous studies, we observed that telomeres of mouse ES cells were much longer than those of mouse embryonic fibroblasts (MEFs) of the same genetic background (5) , which are typically obtained at embryonic day 13.5 (E13.5) . This observation raised the issue of whether blastocyst inner cell mass (ICM) cells, which are the natural equivalents of ES cells, also have hyper-long telomeres. If this is the case, then telomeres must shorten during fetal development, despite high telomerase activity (6) (7) (8) . An alternative explanation emerges, however, that hyper-long telomeres in ES cell are aberrant and may result from the in vitro establishment and expansion of ES cells.
ES-like pluripotent stem cells can be generated from differentiated cells (i.e., MEFs) by using defined factors, giving rise the so-called induced pluripotent stem (iPS) cells, which are considered functional equivalents of ES cells (9) (10) (11) (12) (13) (14) (15) (16) . We recently showed that iPS telomeres increase in length during and after nuclear reprogramming until reaching ES cell hyper-long telomeres. This elongation process occurs concomitantly to lower density of trimethylated histones H3K9 and H4K20 at the telomeric chromatin (5) . Furthermore, hyper-long telomeres were not observed in iPS cells derived from first-generation telomerasedeficient MEFs, indicating that they do not originate from a selective reprogramming of a subset of parental cells with very long telomeres; instead, they result from an active telomere elongation by telomerase during and after nuclear reprogramming (5) . Notably, early passage iPS cells had shorter telomeres than those of ES cells from the same genetic background and only acquired ES cell-like hyper-long telomeres after several passages in vitro (5) . These findings suggest that hyper-long telomeres in iPS cells are the consequence of in vitro expansion of these cells, lending support to the possibility that a similar scenario may be true also for established mouse ES cell lines.
Results
To directly address these possibilities, we first analyzed telomere length at different stages of mouse embryonic and fetal development, including morula, blastocyst, E7.5, E10.5, and E13.5 (Materials and Methods). Embryo sections were hybridized with a telomeric probe and telomere length was measured at a singlecell level by using the telomapping technique (6) (Materials and Methods). We observed that average telomere length significantly increased from morula to the blastocyst stage (Fig. 1A) and that, although average telomere length was shorter at E7.5 compared with the blastocyst stage, it was maintained constant from E7.5 until E13.5, in agreement with the presence of high telomerase activity throughout embryo development (8, (17) (18) (19) (20) (21) . Strikingly, ES cells processed in parallel showed much longer telomeres than those of blastocyst cells (Fig. 1A) . To discard that differences in telomere length are caused by changes in probe accessibility, chromatin status associated to developmental stage, or ploidy, we performed quantitative-FISH (Q-FISH) with a centromeric major satellite probe and found no significant differences in centromeric fluorescence (Materials and Methods and Fig. S1 ). In this regard, centromeres and telomeres have been reported to share the same heterochromatic marks (22) . We next performed a separate analysis of telomere length in trophectoderm (TE) cells versus ICM cells within the same blastocysts by using telomapping. Blastocysts cells were grouped into three categories according to their average telomere fluorescence intensity and a color was associated to each group (Fig. 1B, Top) . Most of the cells with the longest telomeres (red color) localize to the ICM, and only a few to the trophectoderm (Fig. 1B) , and the mean telomere length for the ICM was significantly higher compared with the TE (Fig. 1B,  Bottom) . Notably, telomeres of ICM cells were shorter than those of established ES-cell lines, suggesting that ES-cell telomeres undergo a significant lengthening during ES-cell in vitro expansion, in analogy to that previously reported for iPS cells (5) . To test this finding, we analyzed in-parallel telomere length in blastocysts and two independent ES-cell lines at both early and late passages by telomapping. Mean telomere length of the ICM was significantly higher than that of the MEFs and trophectoderm cells and of a similar length to early passage ES cells (passage 5) (89 and 83 Kb, respectively) (Fig. 1C) . Telomere length further increased from passage 5 (83 kb) to passage 12 (around 125 kb) (Fig. 1C) . In addition, the increased recombination rates of ES cells compared with MEFs (23) could account for the increased heterogeneity in telomere length found in increasing passages of ES cells. By performing Q-FISH with a centromeric major satellite probe, we ruled out that these differences in telomere length were because of changes in probe accessibility, chromatin status, or ploidy (Materials and Methods and Fig. S2 ). Of relevance, this continuous increment of telomere length over passages in pluripotent cells is not observed in established immortal human (Fig. S3 ) or mouse cell lines (24) , which show stable telomeres over passages. To test whether telomere length was further increased after passage 12, we expanded the cells until passage 31 and performed telomapping analysis. We found that telomeres continued to increase their length at these late passages, although the difference between passage 24 and 31 was not statistically significant (Fig. S4 ). In conclusion, the reset of telomere length during development happens at the blastocyst stage, in accordance with a previous report showing telomere elongation at the transition from morula to blastocyst (25) . Importantly, we first demonstrate here that the longest telomeres within blastocysts localize to the ICM, suggesting that telomere elongation specifically occurs in this subset of pluripotent embryonic cells. In addition, ES cells undergo a further increase in telomere length compared with ICM cells of the blastocyst.
The telomere length of the blastocyst ICM was comparable to that of ES cells at passage 5, raising the possibility that telomere length of established ES cells was inherited from the blastocyst ICM, and telomere lengthening restricted to in vitro expansion of established ES cell lines. To test this hypothesis, we sought to analyze in-depth telomere dynamics at the earliest steps during establishment of ES cells. The very first step is the in vitro ICM, obtained from 3.5-d blastocysts upon removal of the zona pellucida. After a few days, colonies of about 1,000 cells are formed (scheme in Fig. 1D ; images of ICM colonies in Fig. S5 ; see also Materials and Methods). In vitro ICM colonies are individually trypsinized and transferred to 96-well plates, where ES cells start to emerge. Further expansion leads to the establishment of ES cells (Fig. 1D) . We measured telomere length by telomapping in the ICM and troph- Telomere length (a. u.) oblasts in blastocysts, in cultured ICM, in the ICM-derived cells grown in 96-well plates, and in established ES-cell lines at passages 5, 9, and 12 (see scheme in Fig. 1D ). We also included iPS cells at both early and late passages. We confirmed that telomeres lengthen during in vitro expansion of ES cells (80 kb at passage 5 compared with 123 kb at passage 12) (Fig. 1E) . Similarly, iPS-cell telomeres increased with passages ( Fig. 1E ) (5) . Interestingly, telomeres from the in vitro ICM (55 kb) were shorter than those of the blastocyst ICM (86 kb) but seemed to recover their length at the 96-well plate (89 kb) (Fig. 1E) , which showed similar telomeres to early passage (passage 5) ES cells (80 kb). We confirmed these findings by using an independent technique based on Southern blotting (telomere restriction fragment analysis, TRF) (Fig. S6) . These results may suggest that the cells from the ICM are susceptible culture-stress-induced telomere-length changes. Indeed, during the establishment of ES-cell lines, the transient ICM of the early blastocyst is forced to artificially exist and divide for several days in vitro. Under culture conditions, most ICM cells differentiate (only 17% and 38.5% of cells express the pluripotency factors Sox2 and Oct3/4, respectively), which in turn may lead to telomere shortening compared with pluripotent stem cells (5, 6) .
To better understand the dynamics of telomere lengthening in the cultured ICM, and to avoid contamination with feeder cells (irradiated MEFs), we analyzed telomere length after 4 and 7 d of culture, in the absence of feeders, by using telomapping (Fig. S7) . We did not find any statistically significant difference in the telomere length at 4 or 7 d of culture. We also ruled out that mean telomere length of the in vitro cultured ICM was lower than that of the blastocyst ICM because of the contribution of irradiated MEFs.
Next, we set to confirm telomere shortening in the in vitro ICM, as well as telomere lengthening of ES cell over in vitro expansion, by using Q-FISH on metaphase spreads. Metaphase spreads allow analysis of every single telomere at chromosomes of a given metaphase. We confirmed shorter telomeres in the cultivated ICM (50 kb), which increased in length with subsequent passages from a mean telomere length of 112 kb in passage 5 to a mean telomere length of 144 kb in passage 12 ( Fig. 2A and Fig.  S8A ; note that absolute telomere-length values were higher than in the telomapping experiment, most likely because of differences in acquisition and the software used to measure intensity).
To (Fig. 2B and Materials and Methods). At the blastocyst stage, development was stopped and combined telomere FISH/ GFP immunofluorescence was performed (Materials and Methods). We found that average telomere length in GFP-expressing ICM cells (derived from aggregated ES cells) was higher than that of non-GFP-expressing ICM cells (derived from the recipient morulae) (Fig. 2 C and D and Fig. S8B ). These results demonstrate that established ES cells have longer telomeres than the cells of the blastocyst ICM. In addition, these results rule out possible effects of different developmental stages on telomerelength measurements, as we are comparing the same cell type within the blastocyst ICM. In summary, these findings strongly support the unique finding of active mechanisms, leading to very long telomeres in the process of ES-cell line establishment, which are likely to involve telomere elongation by telomerase (5) .
We reasoned that the increase in telomere length observed in established and during the establishment of ES cells could be linked to the structure of chromatin and ultimately to the epigenetic status of telomeres, which is different to that observed in MEFs (5, 22) . To test this idea, we first measured the global-and subtelomeric-DNA methylation (SI Materials and Methods). Because pericentric and subtelomeric repeats remain unaltered between ES and differentiated cells (5, 16), we analyzed the interspersed repeats (SINE repeats) and found no substantial difference in DNA-methylation between the passages of ES cells and MEFs (Fig. S9A) . We found subtelomeric DNA mostly methylated with small variations between the passages, which were not statistically significant (Fig. S9 B-D) . We next analyzed heterochromatic marks at telomeres by performing FISH with a telomere probe combined with immunofluorescence for both trimethylation at lysine 20 of histone H4 (H4k20me3) and at lysine 9 of histone H3 (H3k9me3) ( (Fig. 3 A-D) . Very similar results were observed for H3k9me3 (Fig. 3 E-H) . A lower colocalization of heterochromatic marks with telomeres was also observed during the process of ES cell generation (Fig. 3 C and G) (5). Together, these results indicate a decrease in both H3K9me3 and H4K20me3 heterochromatic marks during the generation of ES cells compared with MEFs, starting in the in vitro ICM. These unprecedented findings suggest that telomere lengthening is concomitant with lower density of heterochromatic marks during the process of EScell establishment. Alternatively, only cells with a more open/lesscompacted chromatin structure are selected from the blastocyst stage to obtain stable ES-cell cultures. Next, we reasoned that the mechanisms leading to telomere elongation during the establishment of ES-cell lines might be linked to pluripotency (30) (31) (32) (33) (34) (35) . Indeed, adult stem-cell compartments bear the cells with the longest telomeres in mice (6) . As a marker for pluripotency, we first tested Nanog, which is required to maintain pluripotency in the mouse epiblast and ES cells (32, 36) . To this end we combined immunofluorescence using a Nanog antibody with FISH for telomeres (Materials and Methods). Again, ICM-cultured cells had shorter telomeres than those from the 96-well plate or established ES cells (Figs. S10 A-C and S11A) . Interestingly, Nanog showed very low expression in the cultivated ICM (3% Nanog-positive cells) (Fig. S10B, Lower graph) , which was dramatically increased at late-passage ES cells (Fig. S10B) . Accordingly, the best positive slope between telomere length and Nanog was found only in established ES cells (Fig. S11B) . These results suggest that Nanog expression and telomere length do not correlate during early stages of establishment of ES-cell lines, and this only occurs at later passages.
Several lines of evidence suggest a link between pluripotency and the telomere-binding proteins, known as shelterins (37) (38) (39) . The shelterin protein TPP1 is essential for telomere elongation by telomerase during reprogramming of MEFs into iPS cells (40) . In addition, deletion of TRF1 causes lethality at the blastocyst stage (41) , and adult tissues conditionally deleted TRF1, show severe stem-cell defects (40, 42) . Thus, we next explored the regulation of TRF1 during establishment of ES cell lines. TRF1 binds and protects telomeres (18, 37, 38) and is proposed to have a role in telomere length regulation (43) (44) (45) (46) . We observed high TRF1 levels already in the cultured ICM compared with primary MEFs (Figs. S10 D-F and S11D ). TRF1 levels were also high in emerging (96-well) and established ES cells, and Nanog showed similar expression to the previous experiment (Fig. S10B) . Thus, high levels of TRF1 were associated with high levels of Nanog expression in emerging or established ES cells, but not in the in vitro ICM. We therefore tested whether TRF1 levels in the in vitro ICM associated to other pluripotency markers. Oct3/4 or Sox2 function in the maintenance of pluripotency in early embryos and established ES cells (47) (48) (49) and are essential for the reprogramming of differentiated cells into iPS (14) (15) (16) . To test this possibility, we performed immunofluorescence with TRF1 and Sox2 (Figs. S10 G-I and S12A). Interestingly, the mean intensity value for Sox2 in the cultured ICM was twice higher than in MEFs, and further increased in emerging and established ES cell lines (Figs. S10H and S12A). Similar results were found when TRF1 and Oct3/4 antibodies were used (Fig. 4 A-C and Fig. S12D ). Of note, the percentage of positive cells for Sox2 and Oct3/4 in the in vitro ICM (17% and 38.5%, respectively) was higher than that of Nanog (3%). Despite the high levels of TRF1 associated to different pluripotency markers at every stage of establishment of ES cells, correlations were poor (Figs. S11 B and C and S12 B and C). To further study a possible correlation between pluripotency factors and TRF1, we used a mouse antibody against Oct3/4 in combination with our best TRF1 antibody. The mouse cell line L5178Y-R, which bears long telomeres but is not pluripotent, was included in our analysis to discard that association of high levels of TRF1 and pluripotency factors are coincidental. Our results show that the cells from the L5178Y-R line had a higher mean TRF1 intensity than MEFs, bur lower than the cultured ICM (Fig. 4 D, F , and H). Oct3/4 levels were basal in primary MEFs and L5178Y-R (Fig. 4 E, G, and H) . Furthermore, we observed a clear correlation between TRF1 and Oct3/4 in established ES cells (Fig. 4I ) and in the in vitro ICM in those cells expressing high levels of Oct3/4. Together, these results indicate that high levels of TRF1 occur in the presence of some pluripotency factors (i.e., Oct3/4) from the earliest step of derivation of ES cells. The unprecedented finding of elevated TRF1 levels before telomere elongation (cultured ICM) could represent a previously unnoticed mechanism to enable cells to protect telomeres as they are elongated. In this manner, limiting TRF1 amounts could also limit further telomere elongation by telomerase.
Discussion
Here, we provide unprecedented evidence that telomeres are specifically elongated in the ICM at the blastocyst stage, and that in vitro cultured ICM cell telomeres undergo a further elongation during the establishment of ES cell lines, which is coordinated with decreased levels of histone trimethylation marks. Thus, in contrast to the intuitive idea of ES cells inheriting long telomeres from the cells of the blastocyst ICM, we show here that there are active mechanisms operating in the process of ES establishment, which act in an orderly manner. We first describe changes in chromatin structure, specifically the loss of heterochromatic marks at early stages of ES cell establishment. In this context, a limited action of the histone metyltranferases Suv39 and Suv420 at telomeres may facilitate the generation of hyper-long telomeres in established ES cell lines, similar to that previously shown by us for iPS cells (26, 27) . Second, our results provide evidence for high expression of TRF1 associated to early stages of ES-cell generation (cultivated ICM cells) coincidental with high Sox2 and Oct3/4 levels, and before telomere elongation and presence of high Nanog levels. High TRF1 expression at early stages of ES cell establishment, even before telomere elongation occurs, may be a mechanism to ensure proficient telomere capping, suggesting that the safeguard of chromosome stability could be coupled to pluripotency. Finally, the events described here associated to ES cell establishment, including the loss of heterochromatic marks, high levels of TRF1, and the elongation of telomeres, could also operate in the context of tumorigenesis to maintain cellular immortality.
Materials and Methods
Cell Culture Conditions and Embryo Collection. Cells and embryos used in this work were from the C57BL6 genetic background, unless specified otherwise. ES cells were derived at the Transgenic Mice Unit of the Spanish National Cancer Research Center (CNIO). IPS cells were reprogrammed from primary MEF (5), which were obtained from 13.5-d embryos (50 Isolation of ICM from Blastocysts. Embryos were harvested from E3.5-pregnant females. The zona pellucida was removed by treatment with Tirode's solution and then transferred to a 60-mm plate containing feeder cells (MEFs treated with Mytomicin-C). Blastocysts were cultured in ES-cell medium for 48 h. The outgrowth of the ICM were picked, usually 4 to 6 d after the initial plating, and transferred to a microdrop of trypsin for disaggregation.
Agregation Experiments. For ES cell microinjection, Hsd:ICR(CD-1) morulae were harvested from superovulated females at E2.5 d of gestation. Sixtythree morulae at the eight-cell stage were microinjected with 6 to 10 EGFPexpressing R1 ES cells (of 129 × 1/SvJ × 129S1/Sv genetic background as in ref. 5) . Microinjected embryos were incubated overnight at 37°C under oil. At the blastocyst stage embryos were fixed for analysis.
Quantitative FISH. ES cells and cultured ICM cells were blocked in metaphase with colcemid for 3 h, swollen in hypotonic buffer for 10 min at 37°C, and fixed as described in ref. 51 . Metaphases were dropped on slides and Q-FISH with a telomere or centromere probe was performed as in ref. 28 . TFL-Telo software (52) was used to quantify the fluorescence intensity of telomeres from 5 to 10 metaphases for each datapoint. Microscope settings are described in SI Materials and Methods.
Telomapping of Blastocyst Sections. Quantitative image analysis was performed on confocal RGB images using the Definiens platform (version XD) as in ref. 6 . For details, see SI Materials and Methods.
Immunfluorescence combined with FISH. Immunofluorescence was performed as in ref. 43 (SI Materials and Methods). Samples were fixed in 4% formaldehyde, dehydrated and incubated with a telomere probe labeled with CY3 (Panagene) as described in ref. (28) .
Statistical Analysis. Statistical analyses were performed using the GraphPad Prism software version 5. Mean values reflect the arithmetic mean. Student t test with "two tails" was used to obtain the P value.
